Skip to main content
. 2022 Feb 15;12:834068. doi: 10.3389/fonc.2022.834068

Table 10.

Studies reporting on body image, pain, fatigue/sleep, and post-traumatic stress.

Author Year No. Location Age H&N Subsite Treatment Instrument Study Design Findings
Body Image
Chen et al. (172) 2020 154 China Mostly men, 40-65 years Mostly thyroid, oral cavity, larynx Surgery within past month BIS
HADS
PSSS
SCSQ
Cross-sectional Younger patients (<40y) had significantly higher BIS score (more dissatisfaction), which is associated with higher anxiety.
Clarke et al. (173) 2014 49 United Kingdom Mean 60.4 years HNSCC (stage III-IV, recurrent, or radiation failure) Mixed DAS24
HADS
Cross-sectional: baseline and 9m No correlation between age & DAS-24 score
Vilaseca et al. (174) 2006 49 USA Mean 62.7 years (44-82 years) Larynx Total laryngectomy UW-QOL Cross-sectional Younger patients more likely to express dissatisfaction with appearance
Zebolsky et al. (175) 2021 103 USA Median 66 years Mixed, mostly oral cavity and cutaneous All involved microvascular reconstruction ARPD
SF scales of the FACE-Q
Retrospective: median time of follow-up at time survey completed 13.5m Age not significantly associated with ARPD or SF scores
Pain
Cramer et al. (176) 2018 175 USA Median 65 years HNC survivors >/=1 y after diagnosis Mixed Pain and QOL assessed with multiple instruments Retrospective Patients <55y more likely than older patients to develop pain (odds ratio of 0.38 for 75+ vs <55)
Moye (177) 2014 170 USA Mean 64.6 years (27-88 years) HNC, esophageal, gastric, or colorectal cancer from the VA
(40% H&N)
Mixed PROMIS
PHQ-9
Prospective: 6m, 12m, & 18m At 6m post-diagnosis, younger adults described higher levels of pain & of pain intensity.
Hassanein et al. (178) 2001 68 United Kingdom Median 58 years Oral cavity, oropharyngeal, maxillary sinus cancer, 6m to 6y post-treatment Mixed UW-QOL
HADS
MAC-Q
SSQ6
Retrospective Young pts (≤60) had more functional problems, highly significant for swallowing & shoulder pain, and significant for pain.
Fatigue/Sleep
Hickok (179) 2005 372 USA Mean age of HNC patients 61 years Receiving RT for cancer (HNC, n=23) RT In-house 12-item symptom inventory Prospective: inventory completed weekly for 5 weeks during RT Age not predictive of fatigue severity at any time point
Rogers et al. (180) 2008 58 USA Mean 60 years Mixed Mixed FSI
PSQI
FACT-Cog
Cross-sectional Fatigue, sleep dysfunction, poorer cognitive function all associated with younger age (all statistically significant)
Santoso et al. (181) 2020 560 The Netherlands Mean 63 years Mixed, patients on prospective NET-QUBIC study Mixed PSQI Cross-sectional, multi-center Younger age significantly associated with poor sleep (p=.049)
PTSD
Holtmaat et al. (182) 2016 74 The Netherlands Median 61.2 years (41-83 years) HNC survivors with psychological distress (HADS-Anxiety or -Depression >7) Mixed PTGI Cross-sectional Age not significantly related to PTGI score
Kangas et al. (183) 2005 82 United Kingdom Not stated New diagnosis of head & neck (n=56) or lung cancer Mixed ASDI
EORTC QLQ-C30
Mini-MAC
PDEQ
BDI-II
STAI-Y
PTCI
DUKE-SS
Prospective: assessed for acute stress disorder at baseline, and for PTSD at 6 months post-diagnosis Incidence of PTSD higher in younger patients (mean age for PTSD 49, vs 61 for no PTSD, p <.05)
Moschopoulou et al. (184) 2018 93 United Kingdom Mean 66 years HNC in follow-up stage and at least 2y out from diagnosis Mixed HADS
ESSI
ALTTIQ
DAS24
QLQ-C30
PCL-C
Cross-sectional Negative association between PCL-C score and age (younger age is associated with posttraumatic stress syndrome)
Posluszny et al. (185) 2014 42 USA Mean 55 years Newly diagnosed HNC pts Mixed PCL-C Prospective study of dyads (patient plus partner) Age not related to PCL score
Richardson et al. (186) 2016 91 New Zealand Not stated Mixed Mixed FACT-H&N
GHQ-12
PSS-SR
Brief COPE
Prospective; baseline & 6m Age not significantly correlated with PTSD at diagnosis or follow-up

ALTTIQ, Assessment of Life Threat and Treatment Intensity;ARPD, Appearance-Related Psychosocial Distress; ASDI, Acute Stress Disorder Inventory; BDI-II, Beck Depression Inventory-II; BIS, Body Image Scale; Brief COPE, Brief Coping Orientation to Problems Experienced Inventory DAS24, Derriford Appearance Scale-24; DUKE-SS, Duke-UNC Functional Social Support Scale; ESSI, ENRICHD Social Support Inventory; FACT-Cog, Functional Assessment of Cancer Therapy-Cognitive; FACT-H&N, Functional Assessment of Cancer Therapy-Head and Neck module; FSI, Fatigue Symptom Inventory H&N, head and neck; GHQ-12, General Health Questionnaire-12; HADS, Hospital Anxiety and Depression Scale; HNC, head and neck cancer; HNSCC, head and neck squamous cell carcinoma; MAC-Q, Memory Complaint Questionnaire; Mini-MAC, Mini-Mental Adjustment to Cancer; NET-QUBIC, Netherlands Quality of Life and Biomedical Cohort; PCL-C, PTSD Checklist-Civilian; PDEQ, peritraumatic dissociative experiences questionnaire PHQ-9, Patient Health Questionnaire-9; PROMIS, Patient Reported Outcomes Measurement Information System; PSSS, Perceived Social Support Scale; PSQI, Pittsburgh Sleep Quality Index; PSS-SR, Posttraumatic Symptom Scale Self-Report versionPTCI, Posttraumatic Concerns Inventory; PTGI, Post-Traumatic Growth Inventory; QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30; SCSQ, Simplified Coping Style Questionnaire; SF, Social Functions; SI, Symptom Inventory; SSQ6, Social Support Questionnaire-Short Form; STAI-Y, State-Trait Anxiety Inventory-Y;UW-QOL, University of Washington Quality of Life Questionnaire; VA, Veterans’ Affairs.